Panostotic Expansile Bone Disease With Massive Jaw Tumor Formation and a Novel Mutation in the Signal Peptide of RANK-Reference-Cited by-同舟云学术

Panostotic Expansile Bone Disease With Massive Jaw Tumor Formation and a Novel Mutation in the Signal Peptide of RANK

Published:2014-03-19 Issue:4 Volume:29 Page:911-921
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Schafer Anne L¹²,Mumm Steven³⁴,El-Sayed Ivan⁵,McAlister William H⁶,Horvai Andrew E⁷,Tom Andrea M⁸,Hsiao Edward C¹,Schaefer Frederick V⁹,Collins Michael T¹⁰,Anderson Mark S¹,Whyte Michael P³⁴,Shoback Dolores M¹²

Affiliation:

1. Department of Medicine; University of California; San Francisco CA USA

2. Endocrine Research Unit; Department of Veterans Affairs Medical Center; San Francisco CA USA

3. Center for Metabolic Bone Disease and Molecular Research; Shriners Hospital for Children; St. Louis MO USA

4. Division of Bone and Mineral Diseases; Washington University School of Medicine at Barnes-Jewish Hospital; St. Louis MO USA

5. Department of Otolaryngology; University of California; San Francisco CA USA

6. Mallinckrodt Institute of Radiology; Washington University School of Medicine at St. Louis Children's Hospital; St. Louis MO USA

7. Department of Pathology; University of California; San Francisco CA USA

8. Department of Medicine; Santa Clara Valley Medical Center; San Jose CA USA

9. Center for Genetic Testing at Saint Francis; Tulsa OK USA

10. National Institute of Dental and Craniofacial Research; National Institutes of Health; Bethesda MD USA

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference28 articles.

1. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation,activation induced by osteoprotegerin ligand;Hsu;Proc Natl Acad Sci USA.,1999

2. RANK is essential for osteoclast and lymph node development;Dougall;Genes Dev.,1999

3. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis;Kong;Nature.,1999

4. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis,regulation of bone mass,calcium metabolism;Li;Proc Natl Acad Sci USA.,2000

5. Mendelian Disorders of RANKL/OPG/RANK Signaling

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy;Bone;2023-05

2. Familial Paget’s disease of bone with ocular manifestations and a novel TNFRSF11A duplication variant (72dup27);Journal of Bone and Mineral Metabolism;2022-12-15

3. Update on the pathogenesis and genetics of Paget’s disease of bone;Frontiers in Cell and Developmental Biology;2022-08-12

4. Non-endemic skeletal fluorosis: Causes and associated secondary hyperparathyroidism (case report and literature review);Bone;2021-04

5. Genetic disorders associated with the RANKL/OPG/RANK pathway;Journal of Bone and Mineral Metabolism;2020-09-17